
Peptide appearance
Lyophilized form helps protect peptide quality. Peptides are supplied as a dry powder, which may look like a compact "puck" or a lighter powder inside the vial.
Because the peptide is dry, it does not require refrigerated shipping during normal transit, including warm seasonal conditions. For longer storage, follow the storage guidance in the product description.
Appearance can vary. The stated peptide content is checked through third-party analysis.
Read more in the product description.
Solution not bundled
Peptides are delivered as lyophilized powder. This dry form helps preserve peptide quality during storage and transport and does not require refrigerated shipping during normal transit.
To prepare a solution, use a solvent such as Bacteriostatic water. It is sold separately, so add it only when you need it for peptide preparation.
Read more in the product description.
Secretagogue peptide
Ipamorelin
In stock
Ipamorelin is a synthetic peptide made of five amino acids and used in ghrelin-receptor research. Published studies look at receptor selectivity, endocrine signals, bone and muscle models, and gut movement.
Order within — · ships today Cutoff 10:00 · local time
Arrives Sep 21 - Sep 23 to Europe
Ipamorelin
44,50 €
Selective GHSR peptide for ghrelin receptor and endocrine marker studies.
Scroll horizontally to reach every product-information tab.
Research overview
Ipamorelin
Ipamorelin is an engineered five-amino-acid peptide, not a full-length natural hormone. Its sequence and terminal changes matter in receptor studies.
Studies cover ghrelin-receptor signals, endocrine responses, bone and muscle models, and gastrointestinal physiology. These observations apply only to the reported study conditions.
Ghrelin-receptor selectivity
Studies compare ghrelin-receptor ligands and measure growth-hormone-, ACTH-, and cortisol-related endpoints. The main question is how selective the ligand is in that assay.
Receptor-probe experiments help separate these signals from broader product claims.
Bone, muscle, and motility models
Other studies measure bone, muscle, metabolic, and postoperative gut-movement endpoints. Each result must stay linked to its own model and controls.
Compound information
Specifications
Molecular profile
- Sequence
- Aib-His-D-2-Nal-D-Phe-Lys-NH2
- Molecular mass
- 711.9 g/mol
- CAS number
- 170851-70-4
- Molecular formula
- C38H49N9O5
Material record
- Physical appearance
- White to off-white lyophilized powder
- Solubility
- Soluble in bacteriostatic water and suitable aqueous laboratory solvents.
- Product note
- Selective growth hormone secretagogue peptide; supplied strictly for research use only.
Laboratory care
Handling
Peptides in transport
Peptides in lyophilized form are supplied in glass vials by standard shipping methods and do not require refrigeration. Short-term temperature fluctuations during transport will not reduce their quality and efficacy. Even at high summer temperatures, the peptides in lyophilized form are stable for several weeks.
Storage of lyophilized peptides
Lyophilized peptides should be stored in a dry place, protected from light and moisture. The following storage conditions are generally recommended:
- Room temperature (15–25 °C): Up to 3 months
- Refrigerated (2–8 °C): Up to 6 months
- Frozen (-20 °C or below): 3–5 years (recommended for long-term storage)
Allow the vial to reach room temperature after taking it out of the refrigerator or freezer.
Storage of reconstituted peptides
Once reconstituted, peptide solutions are generally less stable than their lyophilized form and should be stored under refrigerated conditions whenever possible.
The following storage conditions are generally recommended:
- Room temperature (15–25 °C): Avoid prolonged storage
- Refrigerated (2–8 °C): Typically 4–8 weeks
- Frozen (-20 °C or below): Up to 3–4 months
To preserve peptide integrity, avoid repeated freeze–thaw cycles, as these may accelerate peptide degradation.
Important: Most manufacturers recommend discarding reconstituted peptides within 4 weeks when stored at 2–8 °C. This recommendation is intentionally conservative and may not reflect the actual chemical stability of every peptide. In our own stability studies, many peptides reconstituted in bacteriostatic water showed no detectable degradation after 12 weeks of refrigerated storage. As peptide stability is highly sequence- and formulation-dependent, this result should not be extrapolated to all peptides without supporting stability data.
Analytical documentation
Latest test results
Latest published result
Liquilabs s.r.o.Signed Certificate of Analysis · 10mg
> 99.8%Purity by HPLC
Recorded QC panel
- AssayPeptide screening
- 9.13 mg
- PurityPeptide screening
- > 99.8%
- Identity (FTIR)FTIR spectrum
- 995
- Identity (RT)Retention time
- 0.983
These are the latest published results for this strength. The batch number is printed on each vial. Your supplied batch is confirmed against the matching published record when your order is allocated.
Source record
References
National Center for Biotechnology Information
PubChem Compound Summary: Ipamorelin
Authoritative identity record for Ipamorelin.
PubChem · View source ↗Raun K, Hansen BS, Johansen NL, et al. · 1998
Ipamorelin, the first selective growth hormone secretagogue
Primary receptor-pharmacology study of Ipamorelin.
European Journal of Endocrinology · 10.1530/eje.0.1390552 View source ↗Venkova K, Mann W, Nelson R, et al. · 2009
Efficacy of ipamorelin, a novel ghrelin mimetic, in a rodent model of postoperative ileus
Primary study using Ipamorelin in a defined rodent research model.
Journal of Pharmacology and Experimental Therapeutics · 10.1124/jpet.108.149211 View source ↗Chemical Abstracts Service
CAS Common Chemistry: 170851-70-4
Authoritative CAS Registry Number record for Ipamorelin.
CAS Common Chemistry · View source ↗Gobburu JV, Agersø H, Jusko WJ, Ynddal L · 1999
Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers
Pharmaceutical research · View source ↗Johansen PB, Nowak J, Skjaerbaek C, Flyvbjerg A, Andreassen TT, Wilken M, Orskov H · 1999
Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society · View source ↗Beck DE, Sweeney WB, McCarter MD, Ipamorelin 201 Study Group · 2014
Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients
International journal of colorectal disease · View source ↗Shrestha P, Sabharwal G, Ghaffari G · 2018
A Novel STAT3 Gene Mutation Related Hyper-IgE Syndrome Misdiagnosed as Hidradenitis Suppurativa
Case reports in immunology · View source ↗N. B. Andersen, K. Malmlöf, P. B. Johansen, T. T. Andreassen, G. Ørtoft, and H. Oxlund · 2001
The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation of adult rats
Growth Horm. IGF Res. Off. J. Growth Horm. Res. Soc. Int. IGF Res. Soc ·J. Svensson et al. · 2000
The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats
J. Endocrinol ·N. K. Aagaard et al. · 2009
Growth hormone and growth hormone secretagogue effects on nitrogen balance and urea synthesis in steroid treated rats
Growth Horm. IGF Res. Off. J. Growth Horm. Res. Soc. Int. IGF Res. Soc ·E. Adeghate and A. S. Ponery · 2004



